58
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Algorithmic assessment reveals functional implications of GABRD gene variants linked to idiopathic generalized epilepsy

ORCID Icon
Received 05 Dec 2022, Accepted 27 Jan 2024, Published online: 09 Feb 2024

References

  • Arslan A. Genes, brains, and behavior: imaging genetics for neuropsychiatric disorders. J Neuropsychiatry Clin Neurosci. 2015;27(2):81–92. doi: 10.1176/appi.neuropsych.13080185.
  • Smoller JW, Andreassen OA, Edenberg HJ, et al. Psychiatric genetics and the structure of psychopathology. Mol Psychiatry. 2019;24(3):409–420. doi: 10.1038/s41380-017-0010-4.
  • Arslan A. Mapping the schizophrenia genes by neuroimaging: the opportunities and the challenges. Int J Mol Sci. 2018a;19(1):219. doi: 10.3390/ijms19010219.
  • Aydin O, Unal Aydin P, Arslan A. Development of Neuroimaging-Based biomarkers in psychiatry. Adv Exp Med Biol. 2019;1192:159–195. doi: 10.1007/978-981-32-9721-0_9.
  • Unal-Aydin P, Aydin O, Arslan A. Genetic architecture of depression: where do We stand now? Adv Exp Med Biol. 2021;1305:203–230. doi: 10.1007/978-981-33-6044-0_12.
  • Arslan A. Imaging genetics of schizophrenia in the post-GWAS era. Prog Neuropsychopharmacol Biol Psychiatry. 2018b;80(Pt B):155–165. doi: 10.1016/j.pnpbp.2017.06.018.
  • Oflaz FE, Son ÇD, Arslan A. Oligomerization and cell surface expression of recombinant GABAA receptors tagged in the δ subunit. J Integrative Neurosci. 2019;18(4):341–350. doi: 10.31083/j.jin.2019.04.1207.
  • Zhu S, Noviello CM, Teng J, et al. Structure of a human synaptic GABAA receptor. Nature. 2018;559(7712):67–72. PMID: 29950725; PMCID: PMC6220708. doi: 10.1038/s41586-018-0255-3.
  • Cui L, Wang F, Yin Z, et al. Effects of the LHPP gene polymorphism on the functional and structural changes of gray matter in major depressive disorder. Quant Imaging Med Surg. 2020;10(1):257–268. doi: 10.21037/qims.2019.12.01.
  • Hwang H, Cho G, Jin MJ, et al. A knowledge-based multivariate statistical method for examining gene-brain-behavioral/cognitive relationships: imaging genetics generalized structured component analysis. PLoS One. 2021;16(3):e0247592. doi: 10.1371/journal.pone.0247592.
  • Xie X, Gu J, Zhuang D, et al. Association study of genetic polymorphisms in GABRD with treatment response and dose in methadone maintenance treatment. Per Med. 2021;18(5):423–430. doi: 10.2217/pme-2021-0063.
  • Lek M, Karczewski KJ, Minikel EV, Exome Aggregation Consortium., et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature. 2016;536(7616):285–291. doi: 10.1038/nature19057.
  • Jukic M, Milosavljević F, Molden E, et al. Pharmacogenomics in treatment of depression and psychosis: an update. Trends Pharmacol Sci. 2022;43(12):1055–1069. Advance online publication doi: 10.1016/j.tips.2022.09.011.
  • Alqahtani AM, Kumarappan C, Kumar V, et al. Understanding the genetic aspects of resistance to antidepressants treatment. Eur Rev Med Pharmacol Sci. 2020;24(14):7784–7795. doi: 10.26355/eurrev_202007_22281.
  • Richards S, Aziz N, Bale S, ACMG Laboratory Quality Assurance Committee., et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–424. doi: 10.1038/gim.2015.30.
  • Absalom NL, Lin SXN, Liao VWY, et al. GABAA receptors in epilepsy: elucidating phenotypic divergence through functional analysis of genetic variants. J Neurochem. 2023. doi: 10.1111/jnc.15932. Advance online publication. 10.1111/jnc.15932
  • Arslan A. Pathogenic variants of human GABRA1 gene associated with epilepsy: a computational approach. Heliyon. 2023;9(9):e20218. doi: 10.1016/j.heliyon.2023.e20218.
  • Knowles JK, Helbig I, Metcalf CS, et al. Precision medicine for genetic epilepsy on the horizon: recent advances, present challenges, and suggestions for continued progress. Epilepsia. 2022;63(10):2461–2475. doi: 10.1111/epi.17332.
  • Trowbridge S, Poduri A, Olson H. Early diagnosis and experimental treatment with fenfluramine via the investigational new drug mechanism in a boy with Dravet syndrome and recurrent status epilepticus. Epileptic Disord. 2021;23(6):954–956. doi: 10.1684/epd.2021.1345.
  • Tsimberidou AM, Fountzilas E, Nikanjam M, et al. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020;86:102019. doi: 10.1016/j.ctrv.2020.102019.
  • Guidugli L, Shimelis H, Masica DL, et al. Assessment of the clinical relevance of BRCA2 missense variants by functional and computational approaches. Am J Hum Genet. 2018;102(2):233–248. doi: 10.1016/j.ajhg.2017.12.013.
  • Fogel BL. Interpretation of genetic testing: variants of unknown significance. Continuum (Minneap Minn). 2011;17(2 Neurogenetics):347–352. doi: 10.1212/01.CON.0000396975.87637.86.
  • Goetz T, Arslan A, Wisden W, et al. GABA(A) receptors: structure and function in the basal ganglia. Prog Brain Res. 2007;160:21–41. doi: 10.1016/S0079-6123(06)60003-4.
  • Arslan A. Extrasynaptic δ-subunit containing GABAAreceptors. J Integr Neurosci. 2021;20(1):173–184. doi: 10.31083/j.jin.2021.01.284.
  • Windpassinger C, Kroisel PM, Wagner K, et al. The human gamma-aminobutyric acid a receptor Delta (GABRD) gene: molecular characterisation and tissue-specific expression. Gene. 2002;292(1-2):25–31. doi: 10.1016/s0378-1119(02)00649-2.
  • Stenson PD, Mort M, Ball EV, et al. The human gene mutation database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet. 2014;133(1):1–9. PMID: 24077912; PMCID: PMC3898141. doi: 10.1007/s00439-013-1358-4.
  • Oulas A, Minadakis G, Zachariou M, et al. Selecting variants of unknown significance through network-based gene-association significantly improves risk prediction for disease-control cohorts. Sci Rep. 2019;9(1):3266. doi: 10.1038/s41598-019-39796-w.
  • Arslan A, von Engelhardt J, Wisden W. Cytoplasmic domain of δ subunit is important for the extra-synaptic targeting of GABAA receptor subtypes. J Integr Neurosci. 2014;13(4):617–631. doi: 10.1142/S0219635214500228.
  • Oflaz FE, Son ÇD, Arslan A. Oligomerization and cell surface expression of recombinant GABAA receptors tagged in the δ subunit. J Integr Neurosci. 2019;18(4):341–350. doi: 10.31083/j.jin.2019.04.1207.
  • Sente A, Desai R, Naydenova K, et al. Differential assembly diversifies GABAA receptor structures and signalling. Nature. 2022;604(7904):190–194. doi: 10.1038/s41586-022-04517-3.
  • Braat S, Kooy RF. The GABAA receptor as a therapeutic target for neurodevelopmental disorders. Neuron. 2015;86(5):1119–1130. doi: 10.1016/j.neuron.2015.03.042.
  • Sherry ST, Ward MH, Kholodov M, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–311. doi: 10.1093/nar/29.1.308.
  • Harrison SM, Riggs ER, Maglott DR, et al. Using ClinVar as a resource to support variant interpretation. Curr Protoc Hum Genet. 2016;89(1):8.16.1–8.16.23. doi: 10.1002/0471142905.hg0816s89.
  • Landrum MJ, Lee JM, Benson M, et al. ClinVar: improving access to variant interpretations and supporting evidence. Nucleic Acids Res. 2018;46(D1):D1062–D1067. doi: 10.1093/nar/gkx1153.
  • Sim NL, Kumar P, Hu J, et al. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012;40(Web Server issue):W452–W457. doi: 10.1093/nar/gks539.
  • Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31(16):2745–2747. doi: 10.1093/bioinformatics/btv195.
  • Adzhubei IA, Schmidt S, Peshkin L, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–249. doi: 10.1038/nmeth0410-248.
  • Pejaver V, Urresti J, Lugo-Martinez J, et al. Inferring the molecular and phenotypic impact of amino acid variants with MutPred2. Nat Commun. 2020;11(1):5918. doi: 10.1038/s41467-020-19669-x.
  • Capriotti E, Fariselli P, Casadio R. I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure. Nucleic Acids Res. 2005;33(Web Server issue):W306–W310. doi: 10.1093/nar/gki375.
  • Wheeler DL, Church DM, Lash AE, et al. Database resources of the national center for biotechnology information. Nucleic Acids Res. 2001;29(1):11–16. doi: 10.1093/nar/29.1.11.
  • Edgar RC. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinf. 2004;5:113. doi: 10.1186/1471-2105-5-113.
  • Kitts A, Phan L, Ward M, et al. The database of short genetic variation (dbSNP) 2013 June 30 [updated 2014 apr 3]. In: The NCBI handbook [internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2013. 2nd ed. Available from: https://www.ncbi.nlm.nih.gov/books/NBK174586/
  • Teng S, Michonova-Alexova E, Alexov E. Approaches and resources for prediction of the effects of non-synonymous single nucleotide polymorphism on protein function and interactions. Curr Pharm Biotechnol. 2008;9(2):123–133. doi: 10.2174/138920108783955164.
  • Wu J, Jiang R. Prediction of deleterious nonsynonymous single-nucleotide polymorphism for human diseases. Scientific World J. 2013;2013:675851–675810. doi: 10.1155/2013/675851.
  • Sunyaev S, Ramensky V, Koch I, et al. Prediction of deleterious human alleles. Hum Mol Genet. 2001;10(6):591–597. doi: 10.1093/hmg/10.6.591.
  • Capriotti E, Martelli PL, Fariselli P, et al. Blind prediction of deleterious amino acid variations with SNPs&GO. Hum Mutat. 2017;38(9):1064–1071. doi: 10.1002/humu.23179.
  • Tien MZ, Meyer AG, Sydykova DK, et al. Maximum allowed solvent accessibilites of residues in proteins. PLoS One. 2013; Nov 218(11):e80635. PMID: 24278298; PMCID: PMC3836772. doi: 10.1371/journal.pone.0080635.
  • Levy ED. A simple definition of structural regions in proteins and its use in analyzing interface evolution. J Mol Biol. 2010;403(4):660–670. Epub 2010 Sep 22. PMID: 20868694. doi: 10.1016/j.jmb.2010.09.028.
  • Heyne HO, Artomov M, Battke F, et al. Targeted gene sequencing in 6994 individuals with neurodevelopmental disorder with epilepsy. Genet Med. 2019;21(11):2496–2503. doi: 10.1038/s41436-019-0531-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.